Early recognition and treatment of specific manifestations of<unk>  can substantially decrease complications and improve quality of life. For this reason, individuals with<unk><unk>  are usually screened routinely for retinal angiomas, CNS hemangioblastomas, clear-cell renal carcinomas and pheochromocytomas. CNS hemangioblastomas are usually surgically removed if they are symptomatic. Photocoagulation and cryotherapy are usually used for the treatment of symptomatic retinal angiomas, although anti-angiogenic treatments may also be an option. Renal tumours may be removed by a partial nephrectomy or other techniques such as radiofrequency ablation. Belzutifan is a drug under investigation for the treatment of<unk> -associated renal cell carcinoma.
Von Hippel–Lindau disease
Mowat–Wilson syndrome
Neurofibromatosis type 4
Hurler–Scheie syndrome
Lesch–Nyhan syndrome
Neurofibromatosis type II
Neurofibromatosis type I
Stratton Parker syndrome